MyAverix Finance
US · Healthcare
Seaport Therapeutics, Inc. Common Stock (SPTX)
Biotechnology
Seaport Therapeutics, Inc. Common Stock (SPTX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-22, reported market cap is $821.14M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SPTX
Seaport Therapeutics, Inc. Common Stock (SPTX) — FAQ
What is Seaport Therapeutics, Inc. Common Stock's market cap?
Seaport Therapeutics, Inc. Common Stock (SPTX) has a reported market cap of $821.14M (data as of 2026-05-22).
What is SPTX's P/E ratio?
The price-to-earnings (P/E) ratio for Seaport Therapeutics, Inc. Common Stock (SPTX) is 25.00 (data as of 2026-05-22).
Does Seaport Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Seaport Therapeutics, Inc. Common Stock (SPTX). Check the MyAverix Finance app for the latest dividend data.
What sector is Seaport Therapeutics, Inc. Common Stock in?
Seaport Therapeutics, Inc. Common Stock (SPTX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SPTX listed on?
SPTX is listed on US.
What is Seaport Therapeutics, Inc. Common Stock's net margin?
Seaport Therapeutics, Inc. Common Stock (SPTX) reports a net margin of 0.0% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.